$4,750.00
According to the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years of age) have diabetes worldwide, and this number is expected to rise nearly 50% to approximately 629 million by 2045. More than 1.25 million people have type 1 diabetes in the US alone.
Report Highlights
Key Questions Answered
Overview
According to the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years of age) have diabetes worldwide, and this number is expected to rise nearly 50% to approximately 629 million by 2045. More than 1.25 million people have type 1 diabetes in the US alone.
Blood glucose monitoring is essential for people with diabetes to lower the risk of complications. It is particularly important for those with type 1 diabetes, but also in people with type 2 diabetes who frequently administer insulin and/or suffer from symptomatic blood sugar fluctuations.
Blood glucose monitoring devices include both traditional handheld blood glucose meters (BGMs) used by patients at home and by healthcare practitioners at the point-of-care, and new sophisticated continuous glucose monitoring systems (CGMs) used by type 1 and insulin-dependent type 2 diabetics.
Valued at nearly $8bn in 2018, the global Blood Glucose Monitoring Devices (BGMDs) Market is growing at a fast pace—at a compound annual growth rate (CAGR) of approximately 11%—due to the phenomenal sales growth of new revolutionary CGMs, such as Abbott’s FreeStyle Libre and Dexcom’s G6 CGM. The market is expected to total nearly $13bn by 2023. Growth of CGMs will be offset by a steady decline in the BGMs segment due to continued extreme price competition/downward pricing pressure, lowered test-strip reimbursement, and market saturation of lower-cost meters, among other factors.
The overall BGMDs market is being driven by several positive factors, including:
This comprehensive medical market and technology report provides:
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. Market forecasts are for the 2018-23 time period.
Contents
Executive Summary……………………………………………………………………………………………….. ES-1
i. Diabetes overview………………………………………………………………………………………………..ES-1
ii. Blood glucose monitoring technology ……………………………………………………………………ES-3
iii. Global blood glucose monitoring devices market……………………………………………………ES-4
iv. Competition……………………………………………………………………………………………………….ES-7
v. Methodology………………………………………………………………………………………………………ES-8
vi. Bibliography …………………………………………………………………………………………………….ES-10
Exhibit ES-1: Blood glucose monitoring device sales by product segment, combined market forecast ($m), 2018-23 ……………………………………………………………. ES-5
1. Diabetes Overview ………………………………………………………………………………………………. 1-1
1.1 Prevalence………………………………………………………………………………………………………… 1-1
1.2 Diabetes defined……………………………………………………………………………………………….. 1-1
1.2.1 Symptoms………………………………………………………………………………………….. 1-2
1.2.2 Complications …………………………………………………………………………………….. 1-4
1.2.3 Diagnosis and treatment………………………………………………………………………. 1-4
1.2.4 Cost of diabetes………………………………………………………………………………….. 1-6
1.3 Bibliography ……………………………………………………………………………………………………… 1-7
2. Blood Glucose Monitoring Devices …………………………………………………………………………. 2-1
2.1 Blood glucose meters…………………………………………………………………………………………. 2-1
2.1.1 Abbott……………………………………………………………………………………………….. 2-9
2.1.2 Ascensia Diabetes Care………………………………………………………………………. 2-10
2.1.3 LifeScan/Platinum Equity……………………………………………………………………. 2-13
2.1.4 Roche ………………………………………………………………………………………………. 2-20
2.1.5 Livongo…………………………………………………………………………………………….. 2-22
2.1.6 One Drop/Apple Watch ……………………………………………………………………… 2-23
2.2 Continuous blood glucose monitoring systems……………………………………………………. 2-25
2.2.1 Abbott……………………………………………………………………………………………… 2-29
2.2.2 Dexcom ……………………………………………………………………………………………. 2-39
2.2.3 Medtronic ………………………………………………………………………………………… 2-46
2.3 New or emerging wearable blood glucose monitoring patches……………………………… 2-52
2.3.1 Medtronic: glucose-sensing patch……………………………………………………….. 2-52
2.3.2 Nemaura Medical………………………………………………………………………………. 2-52
2.3.3 Senseonics………………………………………………………………………………………… 2-57
2.3.4 Verily ………………………………………………………………………………………………. 2-62
2.4 Diabetes monitoring mobile apps………………………………………………………………………. 2-64
2.5 Bibliography ……………………………………………………………………………………………………. 2-65
Exhibit 2-1: Accuracy of blood glucose meters – top 8 with lowest MARD ……………………… 2-3
Exhibit 2-2: Selected blood glucose meter brands by manufacturer………………………………. 2-4
Exhibit 2-3: Selected blood glucose meters and features…………………………………………….. 2-5
Exhibit 2-4: The FreeStyle Lite ………………………………………………………………………………… 2-9
Exhibit 2-5: The Contour NEXT One and Contour Diabetes app …………………………………… 2-11
Exhibit 2-6: The Contour NEXT Link 2.4…………………………………………………………………… 2-12
Exhibit 2-7: OneTouch Verio Flex meter with OneTouch Reveal app and OneTouch Verio meter………………………………………………………………………… 2-15
Exhibit 2-8: OneTouch Reveal Plus powered by Welldoc’s BlueStar intelligent diabetes coaching technology ………………………………………………………………. 2-17
Exhibit 2-9: Welldoc’s BlueStar diabetes AI-driven smart app…………………………………….. 2-18
Exhibit 2-10: The new Accu-Chek Guide, Guide me, and mySugr app…………………………….. 2-21
Exhibit 2-11: One Drop Mobile app, glucose meter/accessories, and the Apple Watch …….. 2-24
Exhibit 2-12: Selected continuous glucose monitoring systems by manufacturer…………….. 2-26
Exhibit 2-13: Selected continuous glucose monitoring systems and features………………….. 2-27
Exhibit 2-14: The FreeStyle Libre 14-day CGM System ………………………………………………… 2-32
Exhibit 2-15: The LibreLink app……………………………………………………………………………….. 2-35
Exhibit 2-16: The Dexcom G6 CGM System with extended 10-day sensor ………………………. 2-41
Exhibit 2-17: Dexcom CLARITY diabetes management software …………………………………… 2-43
Exhibit 2-18: The Guardian Connect CGM System with Sugar.IQ app …………………………….. 2-49
Exhibit 2-19: The iPro2 Professional CGM system with CareLink iPro software ……………….. 2-51
Exhibit 2-20: The SugarBEAT system………………………………………………………………………… 2-53
Exhibit 2-21: How the SugarBEAT draws glucose from interstitial fluid ………………………….. 2-54
Exhibit 2-22: Senseonic’s Eversense Continuous Glucose Monitoring System and insertion procedure ……………………………………………………………………………. 2-58
Exhibit 2-23: Verily Lifesciences’ investigational glucose-measuring contact lens ……………. 2-63
3. Market Analysis…………………………………………………………………………………………………… 3-1
3.1 Blood glucose monitoring devices market…………………………………………………………….. 3-1
3.1.1 Market forecast: global………………………………………………………………………… 3-1
3.1.2 Market forecast: by region and segment ……………………………………………….. 3-5
3.1.3 US market ………………………………………………………………………………………….. 3-8
3.1.4 Five major EU markets…………………………………………………………………………. 3-8
3.1.5 Japanese market…………………………………………………………………………………. 3-9
3.1.6 Rest of the world market……………………………………………………………………… 3-9
3.1.7 Market drivers and limiters ………………………………………………………………… 3-10
3.2 Competitive analysis………………………………………………………………………………………… 3-11
3.2.1 Market share: global/combined ………………………………………………………….. 3-12
3.2.2 Market share: by segment………………………………………………………………….. 3-13
3.2.3 Market share: by region……………………………………………………………………… 3-17
3.3 Corporate profiles……………………………………………………………………………………………. 3-19
3.3.1 Abbott……………………………………………………………………………………………… 3-19
3.3.2 Ascensia Diabetes Care………………………………………………………………………. 3-21
3.3.3 Dexcom ……………………………………………………………………………………………. 3-23
3.3.4 Medtronic ………………………………………………………………………………………… 3-28
3.3.5 Nemaura Medical………………………………………………………………………………. 3-31
3.3.6 Roche ………………………………………………………………………………………………. 3-33
3.3.7 Senseonics………………………………………………………………………………………… 3-36
3.4 Bibliography ……………………………………………………………………………………………………. 3-39
Exhibit 3-1: Blood glucose monitoring device sales by product segment, combined market forecast ($m), 2018-23……………………………………………………………….. 3-2
Exhibit 3-2: Blood glucose monitoring devices market, forecast sales by region ($m), 2018-23 ……………………………………………………………………………………………… 3-6
Exhibit 3-3: Blood glucose monitoring device sales by product segment and region, combined market forecast ($m), 2018-23…………………………………………………. 3-7
Exhibit 3-4: Combined blood glucose monitoring devices market, global share by supplier ($m), 2018 ………………………………………………………………………… 3-12
Exhibit 3-5: Blood glucose meters market, global share by supplier ($m), 2018 …………….. 3-13
Exhibit 3-6: Continuous glucose monitoring systems market, global share by supplier ($m), 2018 ………………………………………………………………………… 3-15
Exhibit 3-7: Combined blood glucose monitoring devices market, estimated share by supplier and region, 2018………………………………………………………………… 3-18
Exhibit 3-8: Abbott, revenues by segment, FY2018 …………………………………………………… 3-21
Exhibit 3-9: Dexcom, revenues by segment, FY2018 …………………………………………………. 3-25
Exhibit 3-10: Medtronic, revenues by segment, FY2019………………………………………………. 3-31
Exhibit 3-11: Roche, revenues by segment, FY2018 ……………………………………………………. 3-35
Exhibit 3-12: Senseonics, revenues by segment, FY2018……………………………………………… 3-37
Appendix A: company listing
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!